“Pathophysiology And Management Of Sickle Cell Disease: New Therapeutic Approaches And Disease-Modifying Treatments” (2022) Journal of Pharmaceutical Negative Results, 13(4), pp. 2305–2310. doi:10.47750/ceg2qf48.